Extensive Osteonecrosis After Glucocorticoids: Clinical Response to Bisphosphonate.
Karthik SubbuJordan B RennerJanet E RubinPublished in: JCEM case reports (2022)
Osteonecrosis is a devastating complication of long-term glucocorticoid therapy that has been described in both malignant and nonmalignant diseases. Its incidence has been found to greater than 50% using magnetic resonance imaging in asymptomatic patients, thus osteonecrosis is likely underdiagnosed. Recent studies have suggested that treatment with bisphosphonates can improve pain and mobility and decrease bone marrow edema. We describe a patient with acute lymphoblastic leukemia who presented with debilitating osteonecrosis after treatment with prednisone for a total cumulative dose of 5100 mg. Magnetic resonance imaging revealed extensive infarcts of her bilateral tibiae and femora and left humerus, talus, and calcaneus consistent with osteonecrosis that had persisted for more than 2 years. Her severe knee, shoulder, and ankle pain was treated with 1 dose zolendronic acid. Despite a prolonged acute phase reaction, the patient's symptoms improved with near total resolution of pain.
Keyphrases
- chronic pain
- acute lymphoblastic leukemia
- magnetic resonance imaging
- pain management
- bone marrow
- neuropathic pain
- case report
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mesenchymal stem cells
- prognostic factors
- risk factors
- stem cells
- early onset
- spinal cord
- contrast enhanced
- postoperative pain
- replacement therapy
- rotator cuff
- diffusion weighted imaging